Drug intelligence / Profile preview

10% Sodium Sulfacetamide 5% Sulfur Cleanser

Development stage
Unknown
Lead developer
Seton Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

10% Sodium Sulfacetamide 5% Sulfur Cleanser is a topical combination prescription therapy indicated for the control of acne vulgaris, acne rosacea, and seborrheic dermatitis. Developed and marketed by Seton Pharmaceuticals, this formulation combines sulfacetamide sodium, a sulfonamide antibacterial, with sulfur, a keratolytic and antimicrobial agent. Sulfacetamide sodium acts as a competitive antagonist of para-aminobenzoic acid (PABA), thereby inhibiting bacterial dihydropteroate synthase (DHPS) and disrupting folic acid synthesis necessary for bacterial growth. Sulfur undergoes reduction in the skin to form hydrogen sulfide, which breaks down keratin to promote desquamation and exhibits direct toxicity against Cutibacterium acnes and other surface microbes. This synergistic dual-action approach effectively reduces bacterial proliferation, follicular obstruction, and associated inflammation.

Brand names
AvarAvar CleanserAvar GelAvar GreenAvar LSAvar LS CleanserAvar-EAvar-E EmollientAvar-E GreenAvar-E LSBP 10-1BP10-1BP-10-1BP 10-WashBP10-WashBP-10-WashCerisa WashClarifoam EFCleniaClenia Emollient CreamClenia Foaming WashClenia PlusPlexionPlexion CleanserPlexion SCTPrascionRosanilRosulaRosula CLKRosula Clarifying WashSSS CleanserSulfacet-RSulfacleansSumadanSumaxinSumaxin CPSumaxin Cleansing PadsSumaxin TSSupheraTopisulfVIRTI-SULFZenciaZetacetZma Clear
Other names
10% sodium sulfacetamide and 5% sulfur cleansersodium sulfacetamide + sulfursodium sulfacetamide 10% and sulfur 5% cleansersodium sulfacetamide and sulfursulfacetamide + sulfursulfacetamide sodium + sulfursulfacetamide sodium and sulfur
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on 10% Sodium Sulfacetamide 5% Sulfur Cleanser.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 10% Sodium Sulfacetamide 5% Sulfur Cleanser.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call